«Switching Off Bacterial Resistance»
Presented by CTI Invest on 15.12.2010
BioVersys is a privately held ETH Spin Off company that focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and render antibiotics effective again.
Coach: Dr. Martin Horst
| Founded |
2008 |
| Industry |
Biotech & Life Sciences
|
| Status |
looking for investor |